ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Graft failure"

  • 2017 American Transplant Congress

    A Thirteen-Year Mayo Clinic Retrospective Study of the Syndrome of Rapid Onset ESRD Among Renal Transplant Recipients, 2001-2013.

    M. Onuigbo,1,2 N. Agbasi.3

    1Medicine, Mayo Clinic, Rochester, MN; 2Nephrology, Mayo Clinic Health System, Eau Claire, WI; 3Mental Health, North East London NHS Foundation Trust, Ilford, Essex, United Kingdom

    Introduction: We described the syndrome of rapid onset ESRD (SORO-ESRD), acute yet irreversible renal failure, for the first time in the journal Renal Failure in…
  • 2017 American Transplant Congress

    Venous Thromboembolism and the Risk of Death and Graft Loss in Kidney Transplant Recipients.

    N. Lam,1 A. Garg,2 G. Knoll,3 J. Kim,4 K. Lentine,5 E. McArthur,6 K. Naylor,6 S. Bota,6 M. Sood.3

    1University of Alberta, Edmonton, Canada; 2Western University, London, Canada; 3University of Ottawa, Ottawa, Canada; 4University of Toronto, Toronto, Canada; 5Saint Louis University School of Medicine, St. Louis; 6Institute for Clinical Evaluative Sciences, London, Canada

    Background: The incidence of venous thromboembolism (VTE) in kidney transplant recipients varies widely in the literature. The implications of VTE for morbidity and mortality in…
  • 2017 American Transplant Congress

    Delayed Graft Function[mdash]Less Ominous for ARF or DCD Recipients?

    M. Barrett, A. Smith, K. Woodside, R. Sung.

    University of Michigan, Ann Arbor

    Delayed Graft Function (DGF) is both a transplant outcome and risk factor for graft failure. Kidneys from donors with kidney injury--such as acute renal failure…
  • 2017 American Transplant Congress

    Early Failure of Kidney Transplants in the Current Era.

    I. Helanterä, M. Lempinen.

    Transplantation and Liver Surgery, Helsinki University Hospital, Helsinki, Finland

    A. Purpose: The short-term outcome after kidney transplantation has improved substantially, and immunological complications rarely lead to early graft loss. However, a small proportion of…
  • 2017 American Transplant Congress

    The Associations Between Immunosuppression Use, Loss of Medicare and Kidney Allograft Outcomes.

    A. Hart,1,2 S. Gustafson,2 A. Wey,2 N. Hadley,2 A. Israni.2

    1Hennepin County Medical Center, Minneapolis; 2Scientific Registry of Transplant Recipients, Minneapolis

    Medicare coverage for kidney transplant recipients aged <65 years in the US ends 3 years posttransplant, but a significant proportion of recipients remain on Medicare…
  • 2017 American Transplant Congress

    Serum Alkaline Phosphatase Predicts Graft Failure and Mortality in Kidney Transplant Recipients.

    Y. Kim,1 S. Park,1 S. Yang,2 H. Lee,1 Y. Kim,3 S.-K. Park,4 D. Han,3 I. Jung,5 J. Ha,6 C. Lim,7 Y. Kim,1 J. Lee.7

    1Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea; 2Seoul National University Biomedical Research Institute, Seoul, Republic of Korea; 3Division of Kidney Transplantation, Department of Surgery, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Republic of Korea; 4Internal Medicine, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Republic of Korea; 5Surgery, Seoul National University Boramae Medical Center, Seoul, Republic of Korea; 6Surgery, Seoul National University Hospital, Seoul, Republic of Korea; 7Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea

    Objective: Recent studies showed that high levels of serum alkaline phosphatase (ALP) are associated with all-cause or cardiovascular death among hemodialysis patients. However, there are…
  • 2016 American Transplant Congress

    Duodenal Graft Complications After Pancreas Transplant: Evolving Management.

    D. Al-Adra,1 J. Laurence,2 A. Norgate,1 N. Goldaracena,1 M. Marquez,1 A. Barbas,1 M. Dib,1 M. Selzner,1 M. Cattral.1

    1Department of Surgery, Toronto General Hospital, University of Toronto, Toronto, ON, Canada; 2Royal Prince Alfred Institute of Academic Surgery, University of Sydney, Sydney, New South Wales, Australia.

    Introduction Pancreas transplantation is an established treatment for insulin-dependent-diabetes-mellitus with renal failure. However, complications relating to the transplant duodenum remain a significant cause of morbidity…
  • 2016 American Transplant Congress

    Prolonged Pre-Transplant Dialysis Duration Reverses the “Nephroprotective Effect” in Simultaneous Liver-Kidney Transplant Recipients.

    M. Casey, X. Wen, A. Santos, S. Rehman, K. Womer.

    University of Florida, Gainesville.

    Past literature has suggested that simultaneous liver-kidney(SLK) transplant recipients may experience a nephroprotective effect compared to kidney(Ki) alone transplant recipients. Since hepatorenal syndrome is a…
  • 2016 American Transplant Congress

    Post-Transplantation Hypomagnesemia as a Predictor of Survival Among the Kidney Transplant Population.

    T. Hod, B. Patibandla, A. Chandraker.

    Transplant Research Center, Brigham and women's hospital, Boston, MA.

    We have previously shown a robust relationship between low magnesium in the first year post-transplant and better long-term kidney allograft function. Given this somewhat counterintuitive…
  • 2016 American Transplant Congress

    Subnormothermic Machine Perfusion (SNMP) with a Novel Hemoglobin-Based Oxygen Carrier (HBOC) Solution for Ex Vivo Preservation in Vascularized Composite Allotransplantation (VCA).

    S. Oksuz, R. Schweizer, M. Minervini, B. Banan, V. Gorantla, P. Fontes.

    University of Pittsburgh, Pittsburgh.

    Background: Improved preservation techniques could reduce ischemia-reperfusion injuries (IRI) and allow better matching and allocation of VCA grafts across wider distances. A novel SNMP system…
  • « Previous Page
  • 1
  • …
  • 42
  • 43
  • 44
  • 45
  • 46
  • …
  • 55
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences